CORE
🇺🇦
make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Phase I study of MLN8237—investigational Aurora A kinase inhibitor—in relapsed/refractory multiple myeloma, Non-Hodgkin lymphoma and chronic lymphocytic leukemia
Authors
A Cervantes
André Goy
+39 more
AR Barr
BD Cheson
BG Durie
Craig B. Reeder
D Mahadevan
D Mahadevan
D Ye
EC Dees
Ely Benaim
G Gorgun
H Katayama
Hadi Danaee
Hua Liu
Huifeng Niu
J Dutta-Simmons
J Fu
Jeffrey A. Ecsedy
Jesus G. Berdeja
JR Bischoff
K Fukasawa
KE Hook
Kevin R. Kelly
Kevin T. McDonagh
KR Kelly
M Hallek
M Tomita
MG Manfredi
R Evans
Swaminathan Padmanabhan Iyer
T Hata
T Hirota
T Marumoto
T Marumoto
Thomas C. Shea
UA Matulonis
W Qi
W Qi
X Wang
Xiaofei Zhou
Publication date
Publisher
'Springer Science and Business Media LLC'
Doi
Cite
Abstract
Abstract is not available.
Similar works
Full text
Open in the Core reader
Download PDF
Available Versions
Crossref
See this paper in CORE
Go to the repository landing page
Download from data provider
info:doi/10.1007%2Fs10637-013-...
Last time updated on 01/04/2019